House Rep. Mike Belcher (R-N.H.) has been suffering from ocular migraines for almost two years.
He took his first Pfizer COVID-19 mRNA immunization in April 2021, and things have not been the same since.
Around 12 hours after the shot, Belcher recalled developing symptoms of severe flu and neurological symptoms soon manifested in a matter of days.
One unusual symptom stood out: His vision became strange. He started to notice that the red and green color balance in his eyes would shift, and dark spots would appear in his field of vision.
Belcher would soon be tormented with painful headaches preceded by a blinding light that would cause searing pain at the back of his eyes.
This came along with more serious symptoms, including impaired balance (he was unable to walk in a straight line) and memory problems.
After being transferred from specialist to specialist, Belcher was finally hospitalized in May 2021.
“I was hospitalized for maybe four days, and I was discharged with the diagnosis of protracted ocular migraines with some other names stacked on,” Belcher told The Epoch Times. “I had never had a migraine before, and at that point, I had a migraine for [around] 20-something days straight.”
Reports of Unusual Visual and Neurological Symptoms in the Vaccinated
Alabama-based neurologist and neuroradiologist Dr. Diane Counce told The Epoch Times that since the vaccine rollouts, she has also seen many patients who, after vaccination, would develop migraines, or experience a worsening or increased frequency of symptoms. These migraines would often manifest with temporary blindness.
Counce’s clinic has treated around 300 long-haul and postvaccine patients, and she has noticed that her long-COVID patients tend to have symptom presentations that are more understood, “more textbook presentation,” while the patients who developed symptoms after vaccination may develop more severe and unexplainable symptoms.
A rather puzzling symptom she saw in her vaccinated patients was vision fluctuation, which would be accompanied by other neurological problems. The patients’ visual acuity would decline, but the decline would fluctuate from day to day, with no obvious physical abnormality observed in the eye.
By Marina Zhang
